Personal information

Other IDs

ResearcherID: J-6949-2013

Activities

Collapse all

Works (17)

Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panel

Blood
2024-05-09 | Journal article
DOI: 10.1182/blood.2023020794
Contributors: Nicola Gökbuget; Nicolas Boissel; Sabina Chiaretti; Hervé Dombret; Michael Doubek; Adele Fielding; Robin Foà; Sebastian Giebel; Dieter Hoelzer; Mathilde Hunault et al.
Source: check_circle
Crossref

Management of ALL in adults: 2024 ELN recommendations from a European expert panel

Blood
2024-05-09 | Journal article
DOI: 10.1182/blood.2023023568
Contributors: Nicola Gökbuget; Nicolas Boissel; Sabina Chiaretti; Hervé Dombret; Michael Doubek; Adele Fielding; Robin Foà; Sebastian Giebel; Dieter Hoelzer; Mathilde Hunault et al.
Source: check_circle
Crossref

Real-world evaluation of UK high hyperdiploidy profile using a large cohort of patients provided by HARMONY data platform

Leukemia
2023-12 | Journal article
DOI: 10.1038/s41375-023-02046-0
Contributors: Amir Enshaei; Javier Martinez Elicegui; Esther Anguiano; Jude Gibson; Sulaiman Lawal; Mirella Ampatzidou; Michael Doubek; Adele K. Fielding; Edoardo La Sala; Elizabeth Middleton et al.
Source: check_circle
Crossref

Antibody responses to SARS‐CoV‐2 vaccination in patients with acute myeloid leukaemia and high risk MDS on active anti‐cancer therapies

British Journal of Haematology
2022-08 | Journal article
DOI: 10.1111/bjh.18248
Contributors: Wei Yee Chan; Catherine Zhu; Emilie Sanchez; Rajeev Gupta; Adele K. Fielding; Asim Khwaja; Elspeth M. Payne; Jenny O'Nions
Source: check_circle
Crossref

Antibody responses to SARS-CoV-2 vaccination in patients with acute leukaemia and high risk MDS on active anti-cancer therapies

2022-04-06 | Preprint
DOI: 10.1101/2022.04.05.22273371
Contributors: W.Y. Chan; C. Zhu; E. Sanchez; R. Gupta; A.K Fielding; A. Khwaja; E.M. Payne; J. O’Nions
Source: check_circle
Crossref

JAK-ing up treatment for CRLF2-R ALL

Blood
2022-02-03 | Journal article
DOI: 10.1182/blood.2021014196
Contributors: Adele K. Fielding
Source: check_circle
Crossref

Acute lymphoblastic leukaemia (ALL) things come to those who wait: 60 years of progress in the treatment of adult ALL

British Journal of Haematology
2020-11 | Journal article
DOI: 10.1111/bjh.17166
Contributors: Adele K. Fielding; Anthony H. Goldstone
Source: check_circle
Crossref

Editors’ Introduction to special issue

British Journal of Haematology
2020-11 | Journal article
DOI: 10.1111/bjh.17156
Contributors: Adele K. Fielding; John Barrett
Source: check_circle
Crossref

CD1a is rarely expressed in pediatric or adult relapsed/refractory T-ALL: implications for immunotherapy

Blood Advances
2020-10-13 | Journal article
DOI: 10.1182/bloodadvances.2020002502
Contributors: Sarah Leong; Sarah Inglott; Foteini Papaleonidopoulou; Karen Orfinada; Philip Ancliff; Jack Bartram; Ben Carpenter; Adele K. Fielding; Sara Ghorashian; Victoria Grandage et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Successful remission induction therapy with gilteritinib in a patient with de novo FLT3‐mutated acute myeloid leukaemia and severe COVID‐19

British Journal of Haematology
2020-08 | Journal article
DOI: 10.1111/bjh.16962
Contributors: Andrew J. Wilson; Ethan Troy‐Barnes; Maryam Subhan; Fiona Clark; Rajeev Gupta; Adele K. Fielding; Panagiotis Kottaridis; Marc R. Mansour; Jenny O'Nions; Elspeth Payne et al.
Source: check_circle
Crossref

Development of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Content Validity

Frontiers in Pharmacology
2020-01 | Journal article
DOI: 10.3389/fphar.2020.00209
Source: check_circle
Researchfish

Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Construct Validity Study

Frontiers in Pharmacology
2020-01 | Journal article
DOI: 10.3389/fphar.2020.01308
Source: check_circle
Researchfish

Monitoring MRD in ALL: Methodologies, technical aspects and optimal time points for measurement

Seminars in Hematology
2020-01 | Journal article
DOI: 10.1053/j.seminhematol.2020.06.003
Source: check_circle
Researchfish

Reliability of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure: HM-PRO

Frontiers in Pharmacology
2020-01 | Journal article
DOI: 10.3389/fphar.2020.571066
Source: check_circle
Researchfish

En-Abl-ing treatment of “Ph-like” ALL?

Blood
2019-10-17 | Journal article
DOI: 10.1182/blood.2019002621
Contributors: Adele K. Fielding
Source: check_circle
Crossref

Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission: a position statement of the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL) and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Bone Marrow Transplantation
2019-06-01 | Journal article
DOI: 10.1038/s41409-018-0373-4
Contributors: Sebastian Giebel; David I. Marks; Nicolas Boissel; Frederic Baron; Sabina Chiaretti; Fabio Ciceri; Jan J. Cornelissen; Michael Doubek; Jordi Esteve; Adele Fielding et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

ARF way to Ph+ ALL stratification?

Blood
2018-03-29 | Journal article
DOI: 10.1182/blood-2018-02-829085
Contributors: Adele K. Fielding
Source: check_circle
Crossref

Peer review (3 reviews for 3 publications/grants)

Review activity for BMJ open. (1)
Review activity for Leukemia (1)
Review activity for The lancet. (1)
How many people are using ORCID?